The direct antiplasmodial effects of five structurally-related flavonoids, namely quercetin, rutin, eriodictyol, eriodictyolchalcone and catechin, were analyzed in vitro on P. falciparum. Notably, all these flavonoids, with the only exception of rutin, caused relevant inhibition of P. falciparum growth when given at 1 mM concentration. In addition, they were found to affect greatly the potent antiplasmodial activity of artemisinin, leading to significant additive and even synergistic effects. In particular, quercetin induced a pronounced synergistic effect. The observed synergisms might be conveniently exploited to design new and/or more effective combination therapies.
TuY. (2004) The development of the antimalarial drugs with new type of chemical structure-qinghaosu and dihydroqinghaosu. Southeast Asian Journal of Tropical Medicine and Public Health, 35, 250–251.
2.
BalintGA. (2001) Artemisinin and its derivatives: an important new class of antimalarial agents. Pharmacology and Therapy, 90, 261–265.
3.
DhingraV, Vishweshwar RaoK, Lakshmi NarasuM. (2000) Current status of artemisinin and its derivatives as antimalarial drugs. Life Sciences, 66, 279–300.
4.
PriceRN, NostenF, LuxemburgerC, KuileFO, PaiphunL, ChongsuphajaisiddhiT, WhiteNJ. (1996) Effects of artemisinin derivatives on malaria transmissibility. Lancet, 347, 1654–1658.
5.
TargettG, DrakeleyC, JawaraM, von SeidleinL, ColemanR, DeenJ, PinderM, DohertyT, SutherlandC, WalravenG, MilliganP. (2001) Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. Journal of Infections and Diseases, 183, 1254–1259.
6.
UdomsangpetchR, PipitapornB, KrishnaS, AngusB, PukrittayakameeS, BatesI, SuputtamongkolY, KyleDE, WhiteNJ. (1996) Antimalarial drugs reduce cytoadherence and rosetting Plasmodium falciparum. Journal of Infections and Diseases, 173, 691–698.
7.
O'NeillPM, PosnerGH. (2004) A medicinal chemistry perspective on artemisinin and related endoperoxides. Journal of Medicinal Chemistry, 47, 2945–2964.
8.
HaynesRK., KrishnaS. (2004) Artemisinins: activities and actions. Microbes and Infections, 6, 1339–1346.
9.
CazellesJ., RobertA, MeunierB. (2002) Alkylating capacity and reaction products of antimalarial trioxanes after activation by a heme model. Journal of Organic Chemistry, 67, 609–619.
10.
RobertA, CoppelY, MeunierB. (2002) Alkylation of heme by the antimalarial drug artemisinin. Chemical Communications, 414–415.
11.
RobertA, Dechy-CabaretO, CazellesJ, MeunierB. (2002) From mechanistic studies on artemisinin derivatives to new modular antimalarial drugs. Accademy of Chemical Research, 35, 167–174.
12.
RobertA, Benoit-VicalF, ClaparolsC, MeunierB. (2005) The antimalarial drug artemisinin alkylates heme in infected mice. Procedings of the National Academy of Sciences of the United States of America, 102, 13676–13680.
13.
MessoriL, PiccioliF, EitlerB, BergonziMC, BiliaAR, VincieriFF. (2003) Spectrophotometric and ESI-MS/HPLC studies reveal a common mechanism for the reaction of various artemisinin analogues with hemin. Bioorganic and. Medicinal Chemistry Letters, 13, 4055–4057.
14.
MessoriL, GabbianiC, CasiniA, SiragusaM, VincieriFF, BiliaAR. (2006) The reaction of artemisinins with hemoglobin: a unified picture. Bioorganic and. Medicinal Chemistry, 14, 2972–2977.
15.
Eckstein-LudwigU, WebbRJ, Van GoethemID, EastJM, LeeAG, KimuraM, O'NeillPM, BrayPG, WardSA, KrishnaS. (2003) Artemisinins target the SERCA of Plasmodium falciparum. Nature, 424, 887–889.
16.
World Health Organization, 2001. Antimalarial Drug Combination Therapy: Report of a Technical Consultation. WHO, Geneva.
17.
SannellaAR, MessoriL, CasiniA, VincieriFF, BiliaAR, MajoriG, SeveriniC. (2007) Antimalarial properties of green tea. Biochemical and Biophysical Research Communications, 353, 177–181.
LuJ, PappLV, FangJ, Rodriguez-NietoS, ZhivotovskyB, HolmgrenA. (2006) Inhibition of mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity. Cancer Research, 66, 4410–4418.
20.
BellA. (2005) Antimalarial drug synergism and antagonism: mechanistic and clinical significance. FEMS Microbiological Letters, 253, 171–184.
21.
TragerW, JensenJB. (1976) Human malaria parasites in continuous culture. Science, 93, 673–675.
22.
MaklerMT, RiesJM, WilliamsJA, BancroftJE, PiperRC, GibbinsBL, HinrichsDJ. (1993) Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity. American Journal of Tropical Medicine and Hygiene, 48, 739–741.
23.
LambrosC, VanderbergJP. (1979) Synchronization of Plasmodium falciparum erythrocytic stages in culture. Journal of Parasitology, 65, 418–420.
24.
SeveriniC, MenegonM, SannellaAR, PagliaMG, NarcisoP, MatteelliA, GullettaM, CaramelloP, CantaF, XayavongMV, MouraINS, PieniazekNJ, TaramelliD, MajoriG. (2006) Prevalence of pfcrt point mutations and level of cloroquine resistance in Plasmodium falciparum isolates from Africa, Infections and Genetic Evolution, 6, 262–268.
